Authors:
Luo, Y
Rockow-Magnone, SK
Joseph, MK
Bradner, J
Butler, CC
Tahir, SK
Han, EKH
Ng, SC
Severin, JM
Gubbins, EJ
Reilly, RM
Rueter, A
Simmer, RL
Holzman, TF
Giranda, VL
Citation: Y. Luo et al., Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents, ANTICANC R, 21(1A), 2001, pp. 23-28